Sobre LLY
Eli Lilly e Company é uma líder pharmaceutical company engaged na discovery, development, manufacture, e sale of human pharmaceutical produtos. It focuses on inovadores medicines addressing critical health needs in areas como diabetes, oncology, immunology, neuroscience, obesity, cardiovascular diseases, cancer, e other therapeutic categories incluindo bone muscle joint disorders, endocrine conditions, dermatology, autoimmune diseases, sleep apnea, migraine, e Alzheimer’s disease. A empresa oferece treatments like insulins, GLP-1 therapies for diabetes e obesity, oncology drugs, immunologic agents, e neuroscience produtos. Eli Lilly e Company apoia access initiatives por meio de partnerships for technology transfer e API supply to manufacturers in low- e middle-income countries, ampliando availability of insulins e other therapies in regions like Africa e Bangladesh. It mantém uma robust research e development pipeline targeting non-communicable diseases, with late-stage projects in diabetes, cardiovascular, e oncology areas. Fundada em 1876 e Com sede em Indianapolis, Indiana, Eli Lilly e Company desempenha um papel relevante na global health technology sector by delivering therapies that improve patient outcomes em diverse medical fields.
